0001231919-24-000064.txt : 20240809 0001231919-24-000064.hdr.sgml : 20240809 20240809163924 ACCESSION NUMBER: 0001231919-24-000064 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240809 DATE AS OF CHANGE: 20240809 EFFECTIVENESS DATE: 20240809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chemomab Therapeutics Ltd. CENTRAL INDEX KEY: 0001534248 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 813676773 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-521145 FILM NUMBER: 241193430 BUSINESS ADDRESS: STREET 1: KIRYAT ATIDIM, BUILDING 7 CITY: TEL AVIV STATE: L3 ZIP: 6158002 BUSINESS PHONE: 972-77-331-0156 MAIL ADDRESS: STREET 1: KIRYAT ATIDIM, BUILDING 7 CITY: TEL AVIV STATE: L3 ZIP: 6158002 FORMER COMPANY: FORMER CONFORMED NAME: Anchiano Therapeutics Ltd. DATE OF NAME CHANGE: 20180906 FORMER COMPANY: FORMER CONFORMED NAME: BioCancell Ltd. DATE OF NAME CHANGE: 20111104 D 1 primary_doc.xml X0708 D LIVE 0001534248 Chemomab Therapeutics Ltd. KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 ISRAEL 6158002 972-77-331-0156 ISRAEL Anchiano Therapeutics Ltd. BioCancell Ltd. Corporation true Adi Mor 15 Kafrisin St. Tel Aviv L3 ISRAEL 6901658 Executive Officer Director Sigal Fattal 16 Kanfey Nesharim St. Ramat Gan L3 ISRAEL 5235716 Executive Officer Matthew Frankel c/o Chemomab Therapeutics Ltd. Kiryat Atidim Building 7 Tel Aviv L3 ISRAEL 6158002 Executive Officer Nissim Darvish c/o Chemomab Therapeutics Ltd. Kiryat Atidim Building 7 Tel Aviv L3 ISRAEL 6158002 Director Alan Charles Moses c/o Chemomab Therapeutics Ltd. Kiryat Atidim Building 7 Tel Aviv L3 ISRAEL 6158002 Director Claude Nicaise 319 Redstone Drive Cheshire CT CONNECTICUT 06410 Director Neil Harris Cohen 1400 E, STE 14-105 1 KENDALL SQ, BLDG Cambridge MA MASSACHUSETTS 02139 Director Jill Quigley c/o Chemomab Therapeutics Ltd. Kiryat Atidim Building 7 Tel Aviv L3 ISRAEL 6158002 Director Biotechnology Decline to Disclose 06b false 2024-07-29 false true true true false 0 Oppenheimer & Co. Inc. 249 None None 85 Broad Street New York NY NEW YORK 10004 NY NEW YORK CA CALIFORNIA false 10000000 10000000 0 false 10 400000 0 0 false Chemomab Therapeutics Ltd. /s/ Sigal Fattal Sigal Fattal Chief Financial Officer 2024-08-09